Key statistics
On Friday, Veracyte Inc (VCYT:NMQ) closed at 27.08, 37.25% above the 52 week low of 19.73 set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 27.25 |
---|---|
High | 27.75 |
Low | 26.79 |
Bid | 27.08 |
Offer | 28.00 |
Previous close | 27.52 |
Average volume | 1.12m |
---|---|
Shares outstanding | 78.31m |
Free float | 76.90m |
P/E (TTM) | 64.65 |
Market cap | 2.12bn USD |
EPS (TTM) | 0.4189 USD |
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
- Veracyte Announces that Multiple Afirma GRID Studies Will Be Presented at ENDO 2025
- Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research
- Veracyte to Participate in Upcoming Investor Conferences
- Veracyte Announces First Quarter 2025 Financial Results
- Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
- Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting
- Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
- Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025
More ▼